de la Fuente-Fernandez R - Search Results

1

Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.

Sossi V, Dinelle K, Topping GJ, Holden JE, Doudet D, Schulzer M, Ruth TJ, Stoessl AJ, de la Fuente-Fernandez R. Sossi V, et al. J Neurochem. 2009 Apr;109(1):85-92. doi: 10.1111/j.1471-4159.2009.05904.x. Epub 2009 Jan 22. J Neurochem. 2009. PMID: 19183257 Free article.

2

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.

Sossi V, de La Fuente-Fernández R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, Ruth TJ. Sossi V, et al. J Cereb Blood Flow Metab. 2002 Feb;22(2):232-9. doi: 10.1097/00004647-200202000-00011. J Cereb Blood Flow Metab. 2002. PMID: 11823721

3

The placebo effect in Parkinson's disease.

de la Fuente-Fernández R, Stoessl AJ. de la Fuente-Fernández R, et al. Trends Neurosci. 2002 Jun;25(6):302-6. doi: 10.1016/s0166-2236(02)02181-1. Trends Neurosci. 2002. PMID: 12086748 Review.

4

Parkinson's disease: imaging update.

de la Fuente-Fernández R, Stoessl AJ. de la Fuente-Fernández R, et al. Curr Opin Neurol. 2002 Aug;15(4):477-82. doi: 10.1097/00019052-200208000-00012. Curr Opin Neurol. 2002. PMID: 12151846 Review.

5

Dopamine release in human ventral striatum and expectation of reward.

de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Behav Brain Res. 2002 Nov 15;136(2):359-63. doi: 10.1016/s0166-4328(02)00130-4. Behav Brain Res. 2002. PMID: 12429397 Clinical Trial.

6

Dopamine receptors in Parkinson's disease: imaging studies.

Stoessl AJ, de la Fuente-Fernández R. Stoessl AJ, et al. Adv Neurol. 2003;91:65-71. Adv Neurol. 2003. PMID: 12442664 Review. No abstract available.

7

Age and severity of nigrostriatal damage at onset of Parkinson's disease.

De La Fuente-Fernández R, Lim AS, Sossi V, Adam MJ, Ruth TJ, Calne DB, Stoessl AJ, Lee CS. De La Fuente-Fernández R, et al. Synapse. 2003 Feb;47(2):152-8. doi: 10.1002/syn.10160. Synapse. 2003. PMID: 12454953

8

VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.

De La Fuente-Fernández R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ. De La Fuente-Fernández R, et al. Synapse. 2003 Jul;49(1):20-8. doi: 10.1002/syn.10199. Synapse. 2003. PMID: 12710012

9

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.

de la Fuente-Fernández R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Brain. 2004 Dec;127(Pt 12):2747-54. doi: 10.1093/brain/awh290. Epub 2004 Aug 25. Brain. 2004. PMID: 15329355

10

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms.

Sossi V, de la Fuente-Fernández R, Holden JE, Schulzer M, Ruth TJ, Stoessl J. Sossi V, et al. J Cereb Blood Flow Metab. 2004 Aug;24(8):869-76. doi: 10.1097/01.WCB.0000126563.85360.75. J Cereb Blood Flow Metab. 2004. PMID: 15362717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters